CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
DLG5 R30Q does not predict response to infliximab therapy in Hungarian patients with Crohn's disease
DOI 10.1055/s-2006-943393
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Fischer, K Claes, L Lakatos, I Altorjay, T Molnár, K Palatka, A Kovacs, M Papp, J Osztovits, P Rutgeerts, S Vermeire, J Papp
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe06/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aim: Recent data from Germany have suggested that specific haplotypic variants of the DLG5 gene on chromosome 10q23 are associated with susceptibility to inflammatory bowel disease (IBD). Since DLG5 has been implicated in maintaining intracellular signal transduction and cell-cell contact, it might be hypothesized that DLG5 affects inflammatory responses and, as a consequence, also response to anti-inflammatory ther…
Zitieren
Zitierempfehlung
S Fischer, K Claes, L Lakatos, I Altorjay, T Molnár, K Palatka, A Kovacs, M Papp, J Osztovits, P Rutgeerts, S Vermeire, J Papp (2006) DLG5 R30Q does not predict response to infliximab therapy in Hungarian patients with Crohn's disease. Zeitschrift für Gastroenterologie (06). https://doi.org/10.1055/s-2006-943393
Mit CareLit weiterarbeiten